Daonil-M Tablet SR

Daonil-M Tablet SR is a combination medication that contains Glibenclamide and Metformin, and is prescribed to address type 2 diabetes effectively.

Glibenclamide, a sulfonylurea stimulating insulin release, and Metformin, which improves insulin sensitivity and reduces glucose production in the liver. Together, they offer a comprehensive approach to regulating blood sugar.

Following the prescribed dosage, usually once a day after breakfast or the initial main meal. The dosage may be adjusted based on individual response and blood glucose levels. Regular monitoring and adherence to the prescribed regimen are vital components of successful diabetes management.

While side effects may vary, common ones include nausea, heartburn, and the potential for low blood sugar levels. Serious effects like angioedema may occur. It is essential to report any adverse reactions to healthcare providers promptly.

Caution is advised for individuals with allergies to the components, diabetic ketoacidosis, type 1 diabetes, glucose-6-phosphate dehydrogenase deficiency, or severe liver or kidney disease. Pregnancy and breastfeeding require careful consideration, and ongoing monitoring is crucial for those undergoing stress or medical procedures.

In the event of a missed dose, administer it as soon as possible Yet, if the next scheduled dose is approaching, it is advisable to forget the missed one to prevent a double dosage.